AI Verdict
ISPC has stronger fundamentals based on our AI analysis.
ISPC vs ISCO Fundamental Comparison
| Metric | ISPC | ISCO |
|---|---|---|
| Revenue | $1.9M | $6.9M |
| Net Income | $-5.5M | $-70,000.0 |
| Net Margin | -292.3% | -1.0% |
| ROE | -178.5% | N/A |
| ROA | -61.0% | -1.3% |
| Current Ratio | 0.63x | 0.80x |
| Debt/Equity | 1.12x | N/A |
| EPS | $-1.54 | $-0.01 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ISPC vs ISCO: Frequently Asked Questions
Is ISPC or ISCO a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), ISPC has stronger fundamentals. ISPC is rated STRONG SELL (95% confidence) while ISCO is rated STRONG SELL (92% confidence). This is not investment advice.
How does ISPC compare to ISCO fundamentally?
iSpecimen Inc. has ROE of -178.5% vs International Stem Cell CORP's N/A. Net margins are -292.3% vs -1.0% respectively.
Which stock pays higher dividends, ISPC or ISCO?
ISPC has a dividend yield of N/A or no dividend while ISCO has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ISPC or ISCO for long term?
For long-term investing, consider that ISPC has STRONG SELL rating with 95% confidence, while ISCO has STRONG SELL rating with 92% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ISPC vs ISCO?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ISPC vs ISCO, the AI consensus favors ISPC based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.